Filtros de búsqueda

Lista de obras de

130. Meta-Analysis of Tardive Dyskinesia Rates in Randomized Controlled Studies Comparing First- to Second-Generation Antipsychotics.

artículo científico publicado en 2017

A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia.

artículo científico

A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia

artículo científico

A Collaborative Approach to Identifying Social Media Markers of Schizophrenia by Employing Machine Learning and Clinical Appraisals.

artículo científico

A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 1: Addressing Daily Functioning and Cognitive Impairments Associated with Schizophrenia [Podcast]

artículo científico publicado en 2023

A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 2: Negative Symptoms in Schizophrenia [Podcast]

artículo científico publicado en 2023

A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes

artículo científico publicado en 2015

A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients

artículo científico publicado en 2019

A meta-analysis of factors associated with quality of life in first episode psychosis

artículo científico publicado en 2018

A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy

artículo científico publicado en 2009

A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia

artículo científico publicado en 2002

A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers

artículo científico publicado en 2017

Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference

artículo científico publicado en 2019

Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics

artículo científico publicado en 2004

Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth

artículo científico publicado en 2016

Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials

artículo científico publicado en 2013

Akathisia: an updated review focusing on second-generation antipsychotics

artículo científico publicado en 2009

Ambiguous findings concerning potential advantages of depot antipsychotics: in search of clinical relevance

artículo científico

Analyzing mHealth Engagement: Joint Models for Intensively Collected User Engagement Data.

artículo científico publicado en 2017

Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis

scientific article published on February 2017

Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials

artículo científico publicado en 2008

Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study

artículo científico publicado en 2011

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

artículo científico publicado en 2005

Antipsychotic polypharmacy: A survey study of prescriber attitudes, knowledge and behavior ⬇️

artículo científico publicado el 21 de marzo de 2011

Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales

artículo científico publicado en 2013

Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia

artículo científico publicado en 2015

Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study

artículo científico publicado en 2014

Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study

artículo científico publicado en 2014

Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry

artículo científico publicado en 2013

Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies

artículo científico publicado en 2019

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain

artículo científico publicado en 2012

Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability

artículo científico publicado en 2010

Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis

artículo científico publicado en 2016

Authors' reply

BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis

artículo científico publicado en 2014

Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects

artículo científico publicado en 2002

Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial.

artículo científico publicado en 2017

Benign Ethnic Neutropenia and Clozapine Use: A Systematic Review of the Evidence and Treatment Recommendations

artículo científico publicado en 2016

Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting

Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharma

scientific article published on 19 May 2020

Body mass index identified as an independent predictor of psychiatric readmission.

artículo científico publicado en 2014

COMT genotype and manic symptoms in schizophrenia

artículo científico publicado en 2006

Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents

artículo científico publicado en 2007

Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study

artículo científico publicado en 2014

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

artículo científico publicado en 2009

Changes in Telepsychiatry Regulations during the COVID-19 Pandemic: 17 Countries and Regions' Approaches to an Evolving Healthcare Landscape

artículo científico publicado en 2020

Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results From the KINECT 3 Study

scientific article published on 18 December 2018

Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia

scientific article published on 05 March 2019

Clinical guidelines: Dosing and switching strategies for long-acting risperidone.

artículo científico publicado en 2003

Clinical insights into pharmacogenetics and schizophrenia, part 2.

artículo científico publicado en 2008

Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia.

artículo científico publicado en 2002

Clinical risk factors for the development of tardive dyskinesia

artículo científico publicado en 2018

Clinically Significant Drug-Drug Interactions with Agents for Attention-Deficit/Hyperactivity Disorder

scientific article published on 01 December 2019

Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group

scientific article published on 18 May 2020

Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison

artículo científico publicado en 2007

Clozapine and COVID-19: The authors respond

artículo científico publicado en 2020

Clozapine as a first treatment for schizophrenia

artículo científico publicado en 2003

Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).

artículo científico publicado en 2015

Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study

artículo científico publicado en 2008

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

artículo científico publicado en 2007

Comments on Abilify MyCite

artículo científico publicado en 2018

Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC).

artículo científico publicado en 2010

Comparative utility of aripiprazole and haloperidol in schizophrenia: post hoc analysis of two 52-week, randomized, controlled trials

artículo científico publicado en 2009

Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression

article

Completed and attempted suicides among 18,154 subjects with schizophrenia included in a large simple trial

artículo científico

Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program

artículo científico publicado en 2015

Consensus statement on the use of clozapine during the COVID-19 pandemic

artículo científico publicado en 2020

Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92]

scientific article published on 25 March 2017

Cost of antipsychotic polypharmacy in the treatment of schizophrenia

artículo científico publicado en 2008

Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program

artículo científico publicado en 2016

Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications

artículo científico publicado en 2005

Cultural Influences in Psychiatry-Reply

artículo científico publicado en 2020

DISC1 and neurocognitive function in schizophrenia.

artículo científico publicado en 2005

DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia

artículo científico publicado en 2007

Demographic and clinical correlates of substance use disorders in first episode psychosis

artículo científico publicado en 2017

Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome

artículo científico publicado en 2007

Digital Parent Training for Children with Disruptive Behaviors: Systematic Review and Meta-Analysis of Randomized Trials

artículo científico publicado en 2016

Digital Peer-Support Platform (7Cups) as an Adjunct Treatment for Women With Postpartum Depression: Feasibility, Acceptability, and Preliminary Efficacy Study

artículo científico publicado en 2018

Digital Peer-Support Platform (7Cups) as an Adjunct Treatment for Women With Postpartum Depression: Feasibility, Acceptability, and Preliminary Efficacy Study

Digital Peer-Support Platform (7Cups) as an Adjunct Treatment for Women With Postpartum Depression: Feasibility, Acceptability, and Preliminary Efficacy Study

Digital Trajectories to Care in First-Episode Psychosis

scientific article published on 26 September 2018

Disrupted in Schizophrenia 1 Genotype and Positive Symptoms in Schizophrenia

article

Disturbing Lack of Early Intervention Studies in Bipolar Disorder-Reply

scientific article published on 01 November 2018

Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia

artículo científico publicado en 2008

Do clozapine and risperidone affect social competence and problem solving?

artículo científico publicado en 2004

Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

artículo científico publicado en 2006

Dose and safety concerns of clozapine: Worldwide package inserts need revisions

scientific article published on 08 January 2020

Dr Correll and Colleagues Reply.

artículo científico publicado en 2017

Dr. Nielsen and colleagues reply

artículo científico publicado en 2015

Drs Kane and Correll Reply

scientific article published on 16 June 2020

Duration of Untreated Psychosis in Community Treatment Settings in the United States

artículo científico publicado en 2015

Dysbindin genotype and negative symptoms in schizophrenia.

artículo científico publicado en 2006

Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review

artículo científico publicado en 2015

Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management Options

artículo científico publicado en 2023

Early Prediction of Antipsychotic Response in Schizophrenia ⬇️

artículo científico publicado el 1 de noviembre de 2003

Early identification and high-risk strategies for bipolar disorder

artículo científico publicado en 2007

Early nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychotics

artículo científico publicado en 2013

Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial.

artículo científico publicado en 2015

Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia

artículo científico publicado en 2010

Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial

scientific article published on 15 July 2020

Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies

artículo científico publicado en 2018

Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with nonpsychotic disorders or no psychiatric disorders: results from a 12-month, real-world study

artículo científico publicado en 2012

Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: a 12-month, double-blind, noninferiority study

artículo científico publicado en 2013

Effects of aripiprazole once-monthly on domains of personal and social performance: results from 2 multicenter, randomized, double-blind studies

artículo científico publicado en 2014

Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial.

artículo científico publicado en 2015

Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial

scientific article published on 08 January 2020

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

artículo científico publicado en 2002

Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study

scientific article published on 27 August 2019

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

artículo científico publicado en 2013

Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice.

artículo científico publicado en 2012

Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia

artículo científico publicado en 2006

Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials

artículo científico publicado en 2016

Efficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic Review

artículo científico publicado en 2016

Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder

artículo científico publicado en 2017

Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies

artículo científico publicado en 2016

Elevated blood urea nitrogen and medical outcome of psychiatric inpatients

artículo científico publicado en 2014

Enlight: A Comprehensive Quality and Therapeutic Potential Evaluation Tool for Mobile and Web-Based eHealth Interventions.

artículo científico publicado en 2017

Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment

artículo científico publicado en 2017

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics

artículo científico publicado en 2008

Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials

artículo científico publicado en 2009

Examining Predictors of Real-World User Engagement with Self-Guided eHealth Interventions: Analysis of Mobile Apps and Websites Using a Novel Dataset

article

Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool

artículo científico publicado en 2020

First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder

artículo científico

Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders

artículo científico publicado en 2015

Genetic variation in DTNBP1 influences general cognitive ability

artículo científico publicado en 2006

Genomics and the future of pharmacotherapy in psychiatry

artículo científico publicado en 2007

Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia

artículo científico publicado en 2013

Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis

artículo científico publicado en 2014

ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial.

artículo científico publicado en 2015

Identification of high-risk coronary heart disease patients receiving atypical antipsychotics: single low-density lipoprotein cholesterol threshold or complex national standard?

artículo científico publicado en 2008

Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1.

artículo científico publicado en 2018

Impairments in perceptual competency and maintenance on a visual delayed match-to-sample test in first-episode schizophrenia

artículo científico publicado en 2003

Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patients

artículo científico publicado en 2011

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder - expert consensus survey part 2.

artículo científico publicado en 2018

Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone

artículo científico publicado en 2012

Iron homeostasis alterations and risk for akathisia in patients treated with antipsychotics: A systematic review and meta-analysis of cross-sectional studies

scientific article published on 19 May 2020

Is Transcultural Psychiatry Possible?

artículo científico publicado en 2019

Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia

artículo científico publicado en 2013

Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia

artículo científico publicado en 2008

Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality

artículo científico publicado en 2009

Left middle temporal gyrus activation during a phonemic discrimination task.

artículo científico publicado en 2004

Lessons learned in the conduct of a global, large simple trial of treatments indicated for schizophrenia

artículo científico publicado en 2012

Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder

artículo científico

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic

artículo científico publicado en 2003

Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies

artículo científico publicado en 2013

Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials

scientific article published on 17 December 2012

Long-term effectiveness of oral second-generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta-analysis of direct head-to-head comparisons

artículo científico publicado en 2019

Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia

artículo científico publicado en 2008

Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia

artículo científico publicado en 2013

Longitudinal associations of family burden and patient quality of life in the context of first-episode schizophrenia in the RAISE-ETP study

artículo científico publicado en 2019

Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable: A Database Report and Case Study

Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: missed targets and lost opportunities

scientific article published on 06 March 2007

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

artículo científico publicado en 2004

M16. Valbenazine (NBI-98854) for the Treatment of Tardive Dyskinesia: Analysis by Underlying Psychiatric Diagnosis in Phase III KINECT 3 Study.

artículo científico publicado en 2017

Medical outcome of psychiatric inpatients with admission hyponatremia

artículo científico publicado en 2012

Metabolic effects of treatment with atypical antipsychotics

artículo científico publicado en 2004

Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.

artículo científico publicado en 2006

Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes

scientific article published on April 2009

Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates.

artículo científico publicado en 2005

Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics

artículo científico publicado en 2015

Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis

artículo científico publicado en 2017

Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies

scientific article published on October 2013

O5.5. PSYCHOTIC RELAPSE DURING MAINTENANCE ANTIPSYCHOTIC TREATMENT: A NATIONWIDE STUDY

O7.2. BREAKTHROUGH ON ANTIPSYCHOTIC MAINTENANCE MEDICATION IN A CLINICAL COHORT.

artículo científico publicado en 2018

Obesity and coronary risk in patients treated with second-generation antipsychotics ⬇️

artículo científico publicado el 12 de diciembre de 2010

Objective User Engagement With Mental Health Apps: Systematic Search and Panel-Based Usage Analysis

artículo científico publicado en 2019

Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia

artículo científico publicado en 2009

One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review

artículo científico publicado en 2007

Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia

scientific article published on 17 September 2019

Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study

artículo científico publicado en 2015

Outcomes of Neuroleptic Malignant Syndrome With Depot Versus Oral Antipsychotics: A Systematic Review and Pooled, Patient-Level Analysis of 662 Case Reports

scientific article published on 24 November 2020

Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia

artículo científico publicado en 2016

PM421. Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies.

artículo científico publicado en 2016

Past and Present Progress in the Pharmacologic Treatment of Schizophrenia ⬇️

artículo científico publicado el 1 de septiembre de 2010

Patients' Attitudes Towards Telepsychiatry: Results of a Nationwide, Multisite Survey During the COVID-19 Pandemic

scientific article published on 01 December 2020

Patterns of stress in schizophrenia

artículo científico publicado en 2008

Performance improvement CME: managing schizophrenia

scientific article published on 01 October 2011

Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications

artículo científico publicado en 2013

Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis

artículo científico publicado en 2016

Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: an open-label, parallel-arm, multiple-dose study

artículo científico publicado en 2013

Pharmacologic treatment of schizophrenia

artículo científico publicado en 2010

Predicting Early Warning Signs of Psychotic Relapse From Passive Sensing Data: An Approach Using Encoder-Decoder Neural Networks

scientific article published on 31 August 2020

Predicting antipsychotic drug response - replication and extension to six weeks in an international olanzapine study

artículo científico publicado en 2008

Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia

artículo científico publicado en 2008

Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia

scientific article published on 22 November 2019

Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia

artículo científico publicado en 2008

Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study

artículo científico publicado en 2014

Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.

artículo científico publicado en 2012

Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.

artículo científico publicado en 2009

Psychological well-being and mental health recovery in the NIMH RAISE early treatment program

artículo científico publicado en 2016

Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention

artículo científico publicado en 2017

Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?

artículo científico publicado en 2017

Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis

scientific article published on 01 September 2020

QT interval duration and dispersion in children and adolescents treated with ziprasidone

artículo científico publicado en 2011

Quantifying clinical relevance in the treatment of schizophrenia

artículo científico publicado en 2011

Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives

artículo científico publicado en 2011

Ranking Antipsychotics for Efficacy and Safety in Schizophrenia

scientific article published on 06 November 2019

Rapid clozapine titration in treatment-refractory bipolar disorder

artículo científico publicado en 2014

Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study

artículo científico publicado en 2012

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

artículo científico publicado en 2003

Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders

artículo científico publicado en 2015

Revisiting the Abnormal Involuntary Movement Scale: Proceedings From the Tardive Dyskinesia Assessment Workshop

artículo científico publicado en 2018

Risk factors for medical deterioration of psychiatric inpatients: opportunities for early recognition and prevention

artículo científico

Role of social media and the Internet in pathways to care for adolescents and young adults with psychotic disorders and non-psychotic mood disorders

artículo científico publicado en 2015

Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia.

artículo científico publicado en 2007

SA17. Response to Treatment With Valbenazine (NBI-98854) in Subjects With Tardive Dyskinesia.

artículo científico publicado en 2017

SU1. Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.

artículo científico publicado en 2017

SU14. Characteristics Associated With Relapse in Patients With Schizophrenia: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Cariprazine Relapse Prevention Trial.

artículo científico publicado en 2017

Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials

artículo científico publicado en 2016

Safety and tolerability of antipsychotic polypharmacy

artículo científico publicado en 2012

Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies

artículo científico

Safety and tolerability of long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled studies comparing the same antipsychotics

artículo científico publicado en 2016

Schizophrenia

article

Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis

artículo científico publicado en 2018

Schizophrenia: mechanism of action of current and novel treatments

artículo científico

Serotonin 6 receptor gene and schizophrenia: case-control study and meta-analysis

artículo científico publicado en 2012

Sex differences in frontal lobe white matter microstructure: a DTI study

artículo científico publicado en 2003

Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia

artículo científico publicado en 2003

Structural similarity networks predict clinical outcome in early-phase psychosis

artículo científico publicado en 2019

Subcortical modulation of attentional control by second-generation antipsychotics in first-episode psychosis

artículo científico publicado en 2013

Sudden deaths in psychiatric patients

artículo científico publicado en 2011

Sudden unexpected death in schizophrenia: autopsy findings in psychiatric inpatients

artículo científico

Suicidality and hospitalization as cause and outcome of pediatric psychiatric emergency room visits

artículo científico publicado en 2014

T234. BREAKTHROUGH ON ANTIPSYCHOTIC MAINTENANCE MEDICATION: A STUDY-LEVEL META-ANALYSIS AND META-REGRESSION ANALYSIS.

artículo científico publicado en 2018

Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis

artículo científico publicado en 2017

Tardive dyskinesia among Chinese and Malay patients with schizophrenia

artículo científico publicado en 2002

Tardive dyskinesia and impaired glucose tolerance

artículo científico publicado en 2002

Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis

article by Maren Carbon et al published October 2018 in World Psychiatry

Technology-Assisted Parent Training Programs for Children and Adolescents With Disruptive Behaviors: A Systematic Review.

artículo científico publicado en 2017

Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?

artículo científico publicado en 2013

The Mount Sinai conference on the pharmacotherapy of schizophrenia

artículo científico publicado en 2002

The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future Research

scientific article published on 01 October 2020

The QTc interval and its dispersion in patients receiving two atypical antipsychotics

scientific article published on 20 June 2008

The RAISE early treatment program for first-episode psychosis: background, rationale, and study design

artículo científico

The Role of Clozapine in Treatment-Resistant Schizophrenia

artículo científico publicado en 2016

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence

artículo científico publicado en 2016

The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics.

artículo científico

The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: a pooled analysis of data from the pivotal trials

artículo científico publicado en 2008

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

artículo científico publicado en 2003

The field of schizophrenia: strengths, weaknesses, opportunities, and threats

artículo científico publicado en 2011

The future of pharmacotherapy for schizophrenia

artículo científico publicado en 2003

The genetics of symptom-based phenotypes: toward a molecular classification of schizophrenia

artículo científico publicado en 2008

The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research

scientific article published on 07 January 2020

The relationship between acoustic startle response measures and cognitive functions in Japanese patients with schizophrenia

artículo científico publicado en 2012

The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder

artículo científico

Transforming the Treatment of Schizophrenia in the United States: The RAISE Initiative

artículo científico publicado en 2018

Treatment models and designs for intervention research during the psychotic prodrome

artículo científico publicado en 2003

Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials.

artículo científico publicado en 2018

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

artículo científico publicado en 2016

Use of remote centralized raters via live 2-way video in a multicenter clinical trial for schizophrenia

artículo científico publicado en 2008

Utilizing Machine Learning on Internet Search Activity to Support the Diagnostic Process and Relapse Detection in Young Individuals With Early Psychosis: Feasibility Study

artículo científico publicado en 2020

Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis

artículo científico publicado en 2016

When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature

artículo científico publicado en 2011

White matter changes associated with antipsychotic treatment in first-episode psychosis

artículo científico publicado en 2013

Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms?

artículo científico publicado en 2007

mHealth for Schizophrenia: Patient Engagement With a Mobile Phone Intervention Following Hospital Discharge

artículo científico publicado en 2016

ω-3 Polyunsaturated Fatty Acids to Prevent Psychosis: The Importance of Replication Studies.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda